Due: June 20, 2025
This RPP is focused on establishing a pilot program to demonstrate the enhanced use of pharmacogenomics (PGx) in the Military Health System (MHS) to aid in the treatment for specific medical conditions and improve healthcare delivery and outcomes.
Funding Availability: The U.S. Government (USG) currently has available a total of approximately $2.15 million (M) for this effort, for direct and indirect costs.
Number of anticipated awards: MTEC expects to make a single award to a qualified Offeror to accomplish the scope of work.
Period of performance: The Period of Performance (PoP) is not to exceed 36 months.
This opportunity requires membership in the MTEC Consortium. This Consortium releases numerous opportunities throughout the year, so even if this one may not be right for you, we strongly encourage you to join the consortium, so you are ready for the next opportunity.
Complete the form below and a program representative will reach out to you shortly to support you through the process.